Kidney Cancer UK
Kidney Cancer Clinical Trials: What You Need to Know
Patients with kidney cancer should be thinking about clinical trials at every step of their journey, not just after a line of... Read More
Nutrition in kidney cancer patients
While diet and exercise are a growing concern being addressed in all malignancies, its focus in kidney cancer is still lacking, according... Read More
Meetings with Jo Churchill MP & Cally Palmer
Today our Health Professional Lead, Lucy, attended – along with many other leading cancer charities – the Cancer Charities round table meeting... Read More
Cell therapy trials continues after positive kidney cancer readout
Sweden’s Immunicum has announced detailed results from its mid-stage trial of its oncology cell-based immunotherapy ilixadencel, which it says justify further clinical trials... Read More
Help and support when I needed it
I was diagnosed with the rare kidney cancer condition, ‘von hippel lindau syndrome’ (VHL), in 2015 and the support I received from... Read More
EU follows US & approves Keytruda for 1st line RCC
Merck & Co/MSD’s PD-1 inhibitor Keytruda received FDA approval earlier in 2019 for use alongside Pfizer’s Inlyta (axitinib) in previously untreated patients... Read More
Ilixadencel/Sunitinib Combo Therapy; Positive Results in mRCC
A combination therapy of ilixadencel plus sunitinib (Sutent) achieved complete tumor responses in patients with metastatic renal cell carcinoma (RCC), according to... Read More
keytruda + axitinib cleared as first-line kidney cancer treatment in EU
Merck & Co/MSD’s Keytruda has added first-line kidney cancer treatment to its ever-lengthening list of approved uses in the EU. The latest... Read More
A guide for talking about advanced cancer
Advice for people living with advanced cancer, their friends and family. We are pleased to present this informative document for the benefit... Read More
Glasgow student develops model kidney that could help train cancer surgeons
The 3D model ‘looks and feels’ like a real kidney. A student has used 3D printing technology to create a model of... Read More
Innovative Research for Advanced Kidney Cancer – David Braun
Alicia Morgans and David Braun discuss his innovative research in metastatic kidney cancer which focuses on understanding and improving immunotherapies in kidney... Read More
Setbacks and Advances in RCC Treatment
Given the variability in disease aggressiveness and the lack of highly predictive biomarkers in renal cell carcinoma (RCC), nothing resembling a “one... Read More
Europe Adopts Pembrolizumab + Axitinib as 1st-Line Treatment for Advanced RCC
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), based in Amsterdam, The Netherlands, has adopted... Read More
2/1 schedual Sunitinib better than 4/2, says study
The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis. Alternate... Read More
Outcomes of patients with mccRCC treated with 2nd line VEGFR-TKI
Prior to the approval of nivolumab, a monoclonal antibody targeting programmed death-1 (PD-1), vascular endothelial growth factor-receptor tyrosine kinase inhibitors (VEGFR-TKIs), specifically... Read More
The SMC; how they work and how we work with them
Kidney Cancer Scotland Health Professional, Maureen (Mo) Johnson (below), recently attended the Scottish Medicine Consortium (SMC) Patient Group Partners Meeting in Glasgow.... Read More
Run the London Marathon 2020 for Kidney Cancer UK
The Virgin Money London Marathon is the most iconic marathon in the world. It attracts runners of all abilities who love the... Read More
Finding the light at the end of the tunnel
by Emma Clark, guest blogger Grieving is not only synonymous with death, but with loss generally. My understandings of, and experience with,... Read More
Kidney Cancer Scotland Patient & Carer Survey
Please only take this survey if you are based in Scotland. If you are taking this survey on a phone or tablet,... Read More
Why Do I Volunteer
By Emma Clark I have chosen to volunteer with Kidney Cancer Scotland for several reasons.I believe volunteering reflects who you are and... Read More
SMC Recommend nivolumab + ipilimumab for 1st line Rcc
By: Maureen Johnson – RGN, BSc (hons) Physiology Kidney Cancer Scotland and Northern Ireland Health Professional Kidney Cancer Scotland are delighted with... Read More
Why do I volunteer?
By Emma Clark I have chosen to volunteer with Kidney Cancer Scotland for several reasons. I believe volunteering reflects who you are... Read More
Begg and Co. conquer Goatfell
The date? 6th of April. The challenge? To climb the highest peak on the Isle of Arran. The team? Unstoppable. On a... Read More